← Open Payments lookup

ELIZABETH BELLOMY: Open Payments

NPI 1780245837 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,851 in 137 payments from 25 companies in 2025. Trend: 2023 $873 · 2024 $1,682 · 2025 $2,851

Food & beverage: $2,851
CompanyPaymentsAmount
ABBVIE INC.25$306
Axsome Therapeutics, Inc.8$301
GlaxoSmithKline, LLC.13$220
AstraZeneca Pharmaceuticals LP9$196
Astellas Pharma US Inc9$191
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$189
Corcept Therapeutics6$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$160
Kowa Pharmaceuticals America, Inc.7$139
Amgen Inc.11$137

Products named: Auvelity, Veozah, XIFAXAN, VRAYLAR, Korlym, CAPLYTA, ZORYVE, TRELEGY ELLIPTA.

Industry payments across TX — which companies pay providers there.